• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血酶及凝血酶/血栓调节蛋白复合物对受体结合型尿激酶型纤溶酶原激活剂(pro-uPA)的灭活作用

Inactivation of receptor-bound pro-urokinase-type plasminogen activator (pro-uPA) by thrombin and thrombin/thrombomodulin complex.

作者信息

Wilhelm S, Wilhelm O, Schmitt M, Graeff H

机构信息

Frauenklinik Technischen Universität München, Germany.

出版信息

Biol Chem Hoppe Seyler. 1994 Sep;375(9):603-8. doi: 10.1515/bchm3.1994.375.9.603.

DOI:10.1515/bchm3.1994.375.9.603
PMID:7840902
Abstract

Urokinase-type plasminogen activator (uPA) binds with high affinity to a specific cell surface glycosyl phosphatidyl-inositol (GPI)-anchored receptor, the urokinase receptor (uPAR). Pro-uPA, the enzymatically inactive single-chain form of uPA after having been activated by certain proteases, converts plasminogen into plasmin. This activation of pro-uPA to enzymatically active uPA can be prevented by the action of thrombin on pro-uPA. This inactivation process is accelerated in the presence of thrombomodulin (TM). The present study investigated whether pro-uPA bound to uPAR is still susceptible to inactivation by thrombin in the presence or absence of TM. A truncated soluble form of the uPAR lacking the GPI-anchor was cloned and expressed in CHO-cells (rec-uPAR277). Rec-uPAR277 efficiently inhibited the thrombin-mediated inactivation of pro-uPA up to 90% in a concentration dependent manner. The protective effect of rec-uPAR277 was far less pronounced when thrombin was complexed with TM. Enzyme kinetic experiments with varying concentrations of pro-uPA showed that in the presence of TM the catalytic efficiency (kcat/Km) of thrombin-mediated inactivation raised from 0.010 microM-1 s-1 to 0.50 microM-1 s-1 corresponding to a fifty-fold increase. In the presence of rec-uPAR277, however, the catalytic efficiency dropped by 4.1-fold (0.5 microM-1 s-1 to 0.122 microM-1 s-1). The inactivation kinetics of pro-uPA by thrombin (no TM added) in the presence of an excess of rec-uPAR277 could not be determined since virtually no inactivation occurred. Our data suggest that pro-uPA once bound to uPAR, is significantly protected from inactivation by thrombin.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

尿激酶型纤溶酶原激活剂(uPA)与一种特定的细胞表面糖基磷脂酰肌醇(GPI)锚定受体——尿激酶受体(uPAR)以高亲和力结合。前尿激酶原是uPA的无酶活性单链形式,在被某些蛋白酶激活后可将纤溶酶原转化为纤溶酶。凝血酶作用于前尿激酶原可阻止其激活为有酶活性的uPA。在血栓调节蛋白(TM)存在时,这种失活过程会加速。本研究调查了结合到uPAR上的前尿激酶原在有无TM存在的情况下是否仍易受凝血酶失活作用的影响。一种缺失GPI锚的截短可溶性uPAR形式被克隆并在CHO细胞中表达(重组uPAR277)。重组uPAR277以浓度依赖方式有效抑制凝血酶介导的前尿激酶原失活达90%。当凝血酶与TM结合时,重组uPAR277的保护作用明显减弱。用不同浓度前尿激酶原进行的酶动力学实验表明,在TM存在时,凝血酶介导失活的催化效率(kcat/Km)从0.010微摩尔-1秒-1提高到0.50微摩尔-1秒-1,相当于增加了50倍。然而,在重组uPAR277存在时,催化效率下降了4.1倍(从0.5微摩尔-1秒-1降至0.122微摩尔-1秒-1)。在过量重组uPAR277存在的情况下,由于几乎没有失活发生,所以无法确定凝血酶(未添加TM)对前尿激酶原的失活动力学。我们的数据表明,一旦结合到uPAR上,前尿激酶原就受到显著保护而免受凝血酶失活作用。(摘要截短至250字)

相似文献

1
Inactivation of receptor-bound pro-urokinase-type plasminogen activator (pro-uPA) by thrombin and thrombin/thrombomodulin complex.凝血酶及凝血酶/血栓调节蛋白复合物对受体结合型尿激酶型纤溶酶原激活剂(pro-uPA)的灭活作用
Biol Chem Hoppe Seyler. 1994 Sep;375(9):603-8. doi: 10.1515/bchm3.1994.375.9.603.
2
Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.受体介导的纤溶酶原激活物功能调节:两种直接膜锚定形式的尿激酶对纤溶酶原的激活作用
J Pept Sci. 2000 Sep;6(9):432-9. doi: 10.1002/1099-1387(200009)6:9<432::AID-PSC279>3.0.CO;2-Q.
3
Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells.重组可溶性尿激酶受体作为尿激酶型纤溶酶原激活剂(uPA)的清除剂。对人卵巢癌细胞增殖和侵袭的抑制作用。
FEBS Lett. 1994 Jan 10;337(2):131-4. doi: 10.1016/0014-5793(94)80259-9.
4
Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase.纤溶酶原激活过程中尿激酶细胞受体的功能分析。受体结合对尿激酶原的酶原性质无影响。
J Biol Chem. 1996 Jun 21;271(25):14779-84. doi: 10.1074/jbc.271.25.14779.
5
Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).相互的尿激酶原/纤溶酶原激活动力学——由与聚(D-赖氨酸)结合的尿激酶受体形成的模板所刺激
Eur J Biochem. 1997 Apr 15;245(2):316-23. doi: 10.1111/j.1432-1033.1997.00316.x.
6
Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor.尿激酶催化的尿激酶受体裂解需要完整的糖脂锚。
Biochem J. 2001 Sep 15;358(Pt 3):673-9. doi: 10.1042/0264-6021:3580673.
7
Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin.凝血调节蛋白对单链尿激酶型纤溶酶原激活剂(尿激酶原)凝血酶失活的加速作用。
J Clin Invest. 1991 Nov;88(5):1680-4. doi: 10.1172/JCI115483.
8
Role of the glycosaminoglycan component of thrombomodulin in its acceleration of the inactivation of single-chain urokinase-type plasminogen activator by thrombin.凝血调节蛋白的糖胺聚糖成分在其加速凝血酶使单链尿激酶型纤溶酶原激活剂失活过程中的作用。
Biochem J. 1993 Mar 15;290 ( Pt 3)(Pt 3):655-9. doi: 10.1042/bj2900655.
9
A competitive chromogenic assay to study the functional interaction of urokinase-type plasminogen activator with its receptor.一种用于研究尿激酶型纤溶酶原激活剂与其受体功能相互作用的竞争性显色测定法。
Biol Chem Hoppe Seyler. 1995 Oct;376(10):587-94. doi: 10.1515/bchm3.1995.376.10.587.
10
Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.参与尿激酶-1型抑制剂复合物和尿激酶原与内吞性α2-巨球蛋白受体/低密度脂蛋白受体相关蛋白结合的区域。尿激酶受体保护尿激酶原不与内吞性受体结合的证据。
J Biol Chem. 1994 Oct 14;269(41):25668-76.

引用本文的文献

1
A murine model of myocardial microvascular thrombosis.一种心肌微血管血栓形成的小鼠模型。
J Clin Invest. 1999 Sep;104(5):533-9. doi: 10.1172/JCI7141.